Theravance Biopharma, Inc. Prepaid Expense and Other Assets, Current
Theravance Biopharma, Inc. (TBPH) had Prepaid Expense and Other Assets, Current of $9.71 million as of 2015-09-30, per its 10-Q filed 2015-11-12.
Discontinued › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2017-03-01
- 2015-09-30: Prepaid Expense and Other Assets, Current $9.71M.
- 2015-06-30: Prepaid Expense and Other Assets, Current $10.39M.
- 2015-03-31: Prepaid Expense and Other Assets, Current $6.76M.
- 2014-12-31: Prepaid Expense and Other Assets, Current $6.08M.
| Period end | Prepaid Expense and Other Assets, Current |
|---|---|
| 2015-09-30 | $9.71M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $10.39M 10-Q · filed 2015-08-13 |
| 2015-03-31 | $6.76M 10-Q · filed 2015-05-13 |
| 2014-12-31 | $6.08M 10-Q · filed 2015-11-12 |
| 2014-09-30 | $6.45M 10-Q · filed 2014-11-12 |
| 2014-06-30 | $3.45M 10-Q · filed 2014-08-14 |
| 2014-06-02 | $3.17M 10-K · filed 2017-03-01 |
| 2014-03-31 | $4.49M 10-Q · filed 2014-06-24 |
| 2013-12-31 | $2.57M 10-K · filed 2015-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |